Walker & Dunlop (NYSE:WD) Stock Gets Price Target Reduction from Keefe, Bruyette & Woods

Walker & Dunlop (NYSE:WD) had its price target reduced by Keefe, Bruyette & Woods from $45.00 to $43.00 in a report published on Tuesday,Benzinga reports. They currently have an outperform rating on the financial services provider’s stock.

Other equities analysts also recently issued reports about the company. Citigroup restated a “market outperform” rating on shares of Walker & Dunlop in a research report on Friday, October 16th. Weiss Ratings cut Walker & Dunlop from a “hold (c-)” rating to a “sell (d+)” rating in a report on Tuesday, August 18th. Wall Street Zen upgraded Walker & Dunlop from a “sell” rating to a “hold” rating in a report on Saturday, August 29th. Finally, Citizens Jmp decreased their target price on shares of Walker & Dunlop from $55.00 to $50.00 and set a “market outperform” rating for the company in a research report on Friday, October 16th. Five research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Walker & Dunlop presently has a consensus rating of “Moderate Buy” and an average price target of $59.25.

Walker & Dunlop Stock Up 3.9%

NYSE WD opened at $39.84 on Tuesday. The company has a market capitalization of $1.37 billion, a price-to-earnings ratio of 10.33 and a beta of 1.48. Walker & Dunlop has a twelve month low of $31.40 and a twelve month high of $75.50. The stock has a fifty day simple moving average of $36.68 and a 200 day simple moving average of $47.50.

Walker & Dunlop (NYSE:WD) last announced its earnings results on Thursday, November 5th. The financial services provider reported $0.92 EPS for the quarter, missing the consensus estimate of $0.98 by ($0.06). Walker & Dunlop had a return on equity of 7.25% and a net margin of 2.94%. The company had revenue of $298.45 million for the quarter, compared to analyst estimates of $310.93 million. During the same period in the previous year, the firm posted $1.22 earnings per share. The firm’s quarterly revenue was down 11.6% compared to the same quarter last year.

Institutional Trading of Walker & Dunlop

Institutional investors have recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in shares of Walker & Dunlop during the 2nd quarter worth approximately $289,614,000. Legal & General Group Plc acquired a new position in shares of Walker & Dunlop during the 2nd quarter valued at $4,318,000. Algert Global LLC acquired a new position in shares of Walker & Dunlop during the 2nd quarter valued at $3,766,000. Man Group plc acquired a new position in shares of Walker & Dunlop during the 2nd quarter valued at $5,095,000. Finally, Ieq Capital LLC bought a new position in Walker & Dunlop during the second quarter worth $2,640,000. Institutional investors own 80.97% of the company’s stock.

Key Walker & Dunlop News

Here are the key news stories impacting Walker & Dunlop this week:

• Positive Sentiment: The Q3 earnings call highlighted the company’s resilience amid market volatility, which may have reassured investors despite a challenging quarter. Walker & Dunlop Earnings Call Shows Resilience Amid Volatility
• Negative Sentiment: Q3 adjusted EPS of $0.92 missed the $0.98 consensus estimate, while revenue of $298.45 million fell short of the $310.93 million forecast. Revenue declined 11.6% year over year, and EPS was down from $1.22 a year earlier—signs of continued pressure on results. Walker & Dunlop misses Q3 2026 sales expectations

Walker & Dunlop Company Profile

Walker & Dunlop, Inc is a commercial real estate finance and advisory firm serving property owners, investors and developers across the United States. The company provides financing, investment sales, valuation, research and advisory services for a broad range of commercial real estate assets, including multifamily, office, industrial, retail, hospitality and senior housing properties.

Its financing business arranges debt and equity solutions through relationships with banks, life insurance companies, government-sponsored enterprises and other capital providers.